REM behaviour disorder and neurodegenerative diseases

Area of Science:

• Neurology
• Sleep Medicine
• Neuroscience

Background:

• Rapid-eye movement sleep behaviour disorder (RBD) is a parasomnia characterized by the loss of normal muscle atonia during REM sleep.
• This allows for the enactment of dream content, often involving complex motor behaviors.
• RBD can be idiopathic or secondary to various factors, including medications and other diseases.

Purpose of the Study:

• To review the clinical, pathogenetic, and therapeutic aspects of RBD.
• To highlight the strong association between RBD and neurodegenerative diseases, particularly alpha-synucleinopathies.
• To emphasize the clinical and prognostic significance of RBD as an early marker.

Main Methods:

• This is a review article, synthesizing existing literature.
• It focuses on clinical observations, pathogenetic mechanisms, and therapeutic strategies for RBD.
• Emphasis is placed on the link between RBD and neurodegeneration.

Main Results:

• RBD is strongly associated with alpha-synucleinopathies, such as Parkinson's disease and Lewy body dementia.
• RBD can precede the motor and cognitive symptoms of these neurodegenerative disorders by many years.
• It serves as a potential early diagnostic marker for neurodegenerative conditions.

Conclusions:

• RBD is a significant clinical feature with profound implications for diagnosing and managing neurodegenerative diseases.
• Early identification of RBD can lead to timely interventions and improved patient outcomes.
• Further research into the pathogenetic mechanisms of RBD may offer insights into neuroprotection.